MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
-31.99%
↑ 98% vs avg
Percentile
P45
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-1607.48%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -31.99% |
| Q3 2025 | 18.31% |
| Q2 2025 | -42.84% |
| Q1 2025 | 21.53% |
| Q4 2024 | -91.48% |
| Q3 2024 | 8.90% |
| Q2 2024 | -83.97% |
| Q1 2024 | -20.04% |
| Q4 2023 | -36.52% |
| Q3 2023 | 23.92% |
| Q2 2023 | -34.73% |
| Q1 2023 | 22.18% |
| Q4 2022 | -24.00% |
| Q3 2022 | 72.63% |
| Q2 2022 | -140.59% |
| Q1 2022 | -90.11% |
| Q4 2021 | -267.95% |
| Q3 2021 | -33166.03% |
| Q2 2021 | 105.70% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |